Operating Lease, Liability of VERTEX PHARMACEUTICALS INC / MA from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly Operating Lease, Liability in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
  • VERTEX PHARMACEUTICALS INC / MA Operating Lease, Liability for the quarter ending 31 Dec 2024 was $1,631,500,000, a 327% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $1,631,500,000 +$1,249,800,000 +327% 31 Dec 2024 10-K 13 Feb 2025 2024 FY
Q3 2024 $1,655,000,000 30 Sep 2024 10-Q 05 Nov 2024 2024 Q3
Q4 2023 $381,700,000 -$46,400,000 -11% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q4 2022 $428,100,000 +$17,400,000 +4.2% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q4 2021 $410,700,000 +$49,700,000 +14% 31 Dec 2021 10-K 10 Feb 2023 2022 FY
Q4 2020 $361,000,000 +$265,204,000 +277% 31 Dec 2020 10-K 09 Feb 2022 2021 FY
Q3 2020 $268,500,000 +$197,323,000 +277% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q4 2019 $95,796,000 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q3 2019 $71,177,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $68,374,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $71,004,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.